ASBM and GaBI Webinar Examines Policy Challenges to Interchangeable Biosimilars
Safe Biologics
DECEMBER 8, 2023
The webinar was the fourth in a series covering key health policy issues. View a recording of the webinar here. On November 30, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted I nterchangeable Designation for Biosimilars- Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars.
Let's personalize your content